The present invention provides methods of treating liver steatosis, liver fibrosis and hepatitis C virus (HCV) infection methods described include methods of reducing the incidence of complications associated with HCV and cirrhosis of the liver and methods of reducing viral load, or reducing the time to viral clearance, or reducing morbidity or mortality in the clinical outcomes, in patients suffering from HCV infection.
